Verve unveils early data from second attempt at heart disease gene editing

Verve Therapeutics is trying to swerve the gene editing industry downturn with new results on a potential one-time treatment to lower cholesterol. The experimental gene editing therapy cut bad cholesterol by levels comparable to approved ...